SOLUPRED 20 mg, orodispersible tablet 20 tablets
Active ingredients: Prednisolone sodium metazoate, Prednisolone
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOLUPRED 20 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 20 comprimé(s)
- Marketing authorisation holder
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Oct 2000
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63226984CIP73493687CIP133400934936876Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PREDNISOLONEcomprimé | 20,00 mg · un comprimé | FT |
| MÉTASULFOBENZOATE SODIQUE DE PREDNISOLONEcomprimé | 31,44 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.